Supplementary Figure 1 from Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Peripheral blood lymphocyte, monocyte, and platelet dynamics following sotigalimab and pembrolizumab combination treatment